MAUDE Adverse Event Report: BAUSCH + LOMB ENVISTA INTRAOCULAR LENS

Model Number	EE
Medical Device Problem Codes	Manufacturing, Packaging or Shipping Problem (2975); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes	Corneal Edema (1791); Intraocular Pressure Increased (1937); Visual Impairment (2138); Toxic Anterior Segment Syndrome (TASS) (4469)
Date of Event	03/19/2025
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
The device remains implanted.Investigation of this event is in progress.Recall of device is underway.
Event or Problem Description
It was reported that 1 day after implantation of an intraocular lens (iol) into the left eye (os), strands of fibrin + cell were observed.The patient had a decrease in bcva.Findings (b)(6) 2025: k-clear, 2+ cell ac.Findings (b)(6) 2025: 4+ epith (mce) - seidel 2+ cell.On (b)(6) 2025 the surgeon administered diamox 250mg and burped the wound.Findings (b)(6) 2025: conj clear, k-trace edema, absent epith mce, - seidel, ac 3+ cell.Patient prognosis reported as unknown.Additional information regarding patient prognosis was requested but not received.Medications used during original surgery: intracameral injection-moxifloxacin 0.5%, xylocaine 0.5% mpf, tetracain 0.5% gtss, vigamox 0.05% gtss.The following medications were prescribed: predforte/moxifloxacin/bromfenac tid increased to qid on (b)(6) 2025, timolol (b)(6) 2025), diamox 500mg bid 1 day (b)(6) 2025).
Event or Problem Description
Additional information was received indicating the inflammation/tass resolved after treatment.
Additional Manufacturer Narrative
Additional information: b5, b6, g3, h2, h6, h11.

• Brand Name: ENVISTA INTRAOCULAR LENS
• Common Device Name: INTRAOCULAR LENS
• Manufacturer (Section D): BAUSCH + LOMB; 1400 north goodman street; rochester NY 14609
• Manufacturer (Section G): BAUSCH + LOMB; 21 north park place blvd.; clearwater FL 33759
• Manufacturer Contact: shayan habibi ; 21 north park place blvd.; clearwater, FL 33759 ; 7277246600
• MDR Report Key: 21866315
• Report Number: 0001313525-2025-00067
• Device Sequence Number: 4719228
• Product Code: HQL
• UDI-Device Identifier: 10757770607850
• UDI-Public: (01)10757770607850(17)271130(11)241217(10)3Q33933
• Combination Product (Y/N): N
• Initial Reporter State: FL
• Initial Reporter Country: US
• PMA/510(K) Number: P910056
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2025
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Health Professional,User Facility
• Initial Reporter Occupation: Physician
• Remedial Action: Recall
• Type of Report: Initial,Followup
• Report Date (Section B): 03/20/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Model Number: EE
• Device Catalogue Number: EEU1900
• Device Lot Number: 3Q33933
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 03/20/2025
• Supplement Date Received by Manufacturer: 05/12/2025
• Initial Report FDA Received Date: 04/18/2025
• Supplement Report FDA Received Date: 07/15/2025
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 12/17/2024
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement: RES96594
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: B+L INJECTOR SYSTEM, PROVISC
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 70 YR
• Patient Sex: Unknown